Your browser doesn't support javascript.
loading
The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation.
De Roeck, Laurien; van der Weide, Hiska L; Eekers, Daniëlle B P; Kramer, Miranda C; Alapetite, Claire; Blomstrand, Malin; Burnet, Neil G; Calugaru, Valentin; Coremans, Ida E M; Di Perri, Dario; Harrabi, Semi; Iannalfi, Alberto; Klaver, Yvonne L B; Langendijk, Johannes A; Romero, Alejandra Méndez; Paulsen, Frank; Roelofs, Erik; de Ruysscher, Dirk; Timmermann, Beate; Vitek, Pavel; Weber, Damien C; Whitfield, Gillian A; Nyström, Petra Witt; Zindler, Jaap; Troost, Esther G C; Lambrecht, Maarten.
Afiliação
  • De Roeck L; KU Leuven, University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium. Electronic address: Laurien.deroeck@uzleuven.be.
  • van der Weide HL; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Eekers DBP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands.
  • Kramer MC; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Alapetite C; Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France.
  • Blomstrand M; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Burnet NG; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Calugaru V; Institute Curie, Paris, France; Institute Curie, Centre de Protonthérapie d'Orsay, Orsay, France.
  • Coremans IEM; Leiden University Medical Centre, Department of Radiotherapy, The Netherlands; Holland Proton Therapy Centre, Delft, The Netherlands.
  • Di Perri D; Department of Radiation Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium; Particle Therapy Interuniversitary Center Leuven (PartICLe), Belgium.
  • Harrabi S; Heidelberg Ion-Beam Therapy Centre (HIT), Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Iannalfi A; National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Klaver YLB; Holland Proton Therapy Centre, Delft, The Netherlands.
  • Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Romero AM; Holland Proton Therapy Centre, Delft, The Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Paulsen F; Department of Radiation Oncology, Eberhard-Karls-Universität Tübingen, Germany.
  • Roelofs E; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands.
  • de Ruysscher D; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands.
  • Timmermann B; Clinic for Particle Therapy, University Hospital Essen, West German Cancer Center (WTZ), Germany; West German Proton Therapy Center Essen (WPE), Germany; German Cancer Consortium (DKTK), partnersite Essen, Germany.
  • Vitek P; Proton Therapy Center Czech, Prague, Czech Republic.
  • Weber DC; Paul Scherrer Institut Center for Proton Therapy, ETH Domain, Villigen, Switzerland.
  • Whitfield GA; The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, United Kingdom; The Children's Brain Tumour Research Network, University of Manchester, Royal Manchester Children's Hospital, United Kingdom.
  • Nyström PW; Danish Centre for Particle Therapy, Aarhus, Denmark; Norwegian Radiation and Nuclear Safety Authority, Oslo, Norway.
  • Zindler J; Holland Proton Therapy Centre, Delft, The Netherlands; Haaglanden Medisch Centrum, Department of Radiotherapy, Leidschendam, The Netherlands.
  • Troost EGC; German Cancer Consortium (DKTK), partnersite Essen, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Germany;
  • Lambrecht M; KU Leuven, University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium; Particle Therapy Interuniversitary Center Leuven (PartICLe), Belgium; Leuven Kanker Instituut (LKI), UZ Leuven Gasthuisbe
Radiother Oncol ; 168: 241-249, 2022 03.
Article em En | MEDLINE | ID: mdl-35093408
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Base do Crânio / Terapia com Prótons Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Base do Crânio / Terapia com Prótons Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article